Hospitalization risk among adults with bipolar I disorder treated with lurasidone versus other oral atypical antipsychotics: a retrospective analysis of Medicaid claims data

CONCLUSIONS: Lurasidone-treated adult Medicaid patients with bipolar I disorder had significantly lower risk of all-cause hospitalization than those treated with olanzapine and quetiapine and lower risk of bipolar I disorder-related hospitalization than quetiapine and risperidone. Bipolar I disorder-related hospital LOS was significantly shorter for patients treated with lurasidone compared to quetiapine.PMID:33682547 | DOI:10.1080/03007995.2021.1897557

Source: Current Medical Research and Opinion - March 8, 2021 Category: Research Authors: Xiaoli Niu Phani Veeranki Syvart Dennen Carole Dembek Kimberly Laubmeier Yanmei Liu G Rhys Williams Antony Loebel Source Type: research